Literature DB >> 10940539

Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors.

R A Glennon1, M Dukat, B Grella, S Hong, L Costantino, M Teitler, C Smith, C Egan, K Davis, M V Mattson.   

Abstract

A large series of beta-carbolines was examined for their ability to bind at [3H]agonist-labeled 5-HT(2A) serotonin receptors. Selected beta-carbolines were also examined at 5-HT(2C) serotonin receptors, 5-HT(1A) serotonin receptors, dopamine D(2) receptors, and benzodiazepine receptors. Indolealkylamines and phenylisopropylamines were also evaluated in some of these binding assays. The beta-carbolines were found to bind with modest affinity at 5-HT(2A) receptors, and affinity was highly dependent upon the presence of ring substituents and ring saturation. The beta-carbolines displayed little to no affinity for 5-HT(1A) serotonin receptors, dopamine D(2) receptors and, with the exception of beta-CCM, for benzodiazepine receptors. Examples of beta-carbolines, indolealkylamines (i.e. N,N-dimethyltryptamine analogs), and phenylisopropylamines have been previously shown to produce common stimulus effects in animals trained to discriminate the phenylisopropylamine hallucinogen DOM (i.e. 1-(2, 5-dimethoxy-4-methylphenyl)-2-aminopropane) from vehicle. Although the only common receptor population that might account for this action is 5-HT(2A), on the basis of a lack of enhanced affinity for agonist-labeled 5-HT(2A) receptors, as well as on their lack of agonist action in the PI hydrolysis assay, it is difficult to conclude that the beta-carbolines behave in a manner consistent with that of other classical hallucinogens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10940539     DOI: 10.1016/s0376-8716(99)00148-9

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  46 in total

Review 1.  Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs?

Authors:  Andrew Holt
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

2.  Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression.

Authors:  Yun Li; Rita Sattler; Eun Ju Yang; Alice Nunes; Yoko Ayukawa; Sadia Akhtar; Grace Ji; Ping-Wu Zhang; Jeffrey D Rothstein
Journal:  Neuropharmacology       Date:  2010-10-27       Impact factor: 5.250

Review 3.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

4.  Harmine treatment enhances short-term memory in old rats: Dissociation of cognition and the ability to perform the procedural requirements of maze testing.

Authors:  Sarah E Mennenga; Julia E Gerson; Travis Dunckley; Heather A Bimonte-Nelson
Journal:  Physiol Behav       Date:  2014-09-22

5.  Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.

Authors:  David J Wagner; Haichuan Duan; Alenka Chapron; Richard W Lee; Joanne Wang
Journal:  Xenobiotica       Date:  2017-03-02       Impact factor: 1.908

6.  Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus.

Authors:  Jucélia J Fortunato; Gislaine Z Réus; Tamires R Kirsch; Roberto B Stringari; Gabriel R Fries; Flávio Kapczinski; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2010-08-05       Impact factor: 3.575

7.  Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.

Authors:  Joseph J Palamar; Austin Le
Journal:  Hum Psychopharmacol       Date:  2019-03-06       Impact factor: 1.672

8.  Harmane inhibits serotonergic dorsal raphe neurons in the rat.

Authors:  Khalid Touiki; Pascal Rat; Robert Molimard; Abderrahman Chait; Renaud de Beaurepaire
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

9.  The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.

Authors:  Richard A Glennon
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

Review 10.  Indolealkylamines: biotransformations and potential drug-drug interactions.

Authors:  Ai-Ming Yu
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.